av/casi-pharmaceuticals--big.svg

NASDAQ:CASI

CASI Pharmaceuticals, Inc.

  • Stock

USD

Last Close

3.29

17/05 20:00

Market Cap

93.25M

Beta: 0.43

Volume Today

15.75K

Avg: 38.23K

PE Ratio

−2.08

PFCF: −7.23

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
2.27M
-
2.95M
29.85%
1.63M
44.68%
4.02M
146.55%
11.01M
173.65%
average payables
453.65K
-
578.54K
27.53%
819.36K
41.63%
974.36K
18.92%
1.58M
61.77%
1.53M
3.06%
3.04M
99.00%
4.39M
44.42%
4.23M
3.69%
4.04M
4.49%
3.86M
4.35%
average receivables
334.65K
-
11.86K
96.46%
11.86K
0%
646.50K
-
2.97M
359.24%
7.22M
143.31%
11.39M
57.64%
11.56M
1.47%
book value per share
5.72
-
-0.15
102.58%
-1.88
1,170.70%
3.72
298.28%
6.27
68.42%
12.92
106.15%
7.61
41.10%
7.38
2.96%
6.21
15.90%
3.27
47.39%
1.81
44.62%
capex per share
-0.02
-
-0.16
891.40%
-0.01
95.20%
-0.04
410.48%
-0.15
280.29%
-2.57
1,590.79%
-1.46
43.12%
-1.75
19.75%
-1.14
34.92%
-0.41
63.89%
-0.17
59.21%
capex to depreciation
-2.47
-
-9.68
291.64%
-0.37
96.16%
-3.36
804.54%
-7.94
136.24%
-13.03
64.20%
-6.51
50.03%
-9.87
51.50%
-8.54
13.44%
-2.32
72.87%
-0.60
74.15%
capex to operating cash flow
0.01
-
0.12
789.64%
0.00
96.05%
0.04
704.62%
0.15
293.92%
0.76
421.77%
0.60
20.82%
0.75
23.78%
0.58
22.66%
0.27
53.91%
0.11
57.83%
capex to revenue
-19.65
-
-0.53
97.29%
-3.39
-
-1.28
62.39%
-0.51
59.75%
-0.13
74.66%
-0.07
49.19%
cash per share
5.79
-
3.73
35.58%
1.58
57.62%
4.85
206.64%
7.07
45.79%
10.04
42.05%
5.65
43.71%
6.01
6.29%
3.57
40.61%
3.76
5.41%
2.30
38.78%
days of inventory on hand
421.30
-
52.06
87.64%
55.43
6.49%
141.55
155.37%
389.06
174.85%
days payables outstanding
36.89K
-
51.43K
39.43%
474.27
-
140.85
70.30%
139.20
1.17%
75.85
45.51%
108.75
43.38%
days sales outstanding
365.00
-
114.24
-
111.98
1.99%
118.61
5.92%
109.85
7.39%
109.22
0.57%
debt to assets
0.12
-
0.25
104.58%
0.05
78.60%
0.03
38.25%
0.01
60.21%
0.02
62.20%
0.01
52.84%
0.02
54.84%
0.01
10.83%
0.26
1,766.74%
debt to equity
-3.29
-
-0.24
92.69%
0.07
129.82%
0.04
45.80%
0.01
64.77%
0.03
120.12%
0.02
47.45%
0.03
61.77%
0.03
17.63%
0.81
2,593.15%
dividend yield
earnings yield
-0.13
-
-0.69
423.83%
-0.23
66.42%
-0.15
36.40%
-0.05
63.39%
-0.08
49.67%
-0.17
115.04%
-0.19
10.74%
-0.35
80.66%
-1.61
365.06%
-0.28
82.54%
enterprise value
28.50M
-
28.75M
0.89%
27.48M
4.42%
38.65M
40.63%
157.93M
308.64%
258.00M
63.36%
245.06M
5.01%
270.06M
10.20%
72.35M
73.21%
-21.34M
129.50%
99.81M
567.76%
enterprise value over ebitda
-4.98
-
-4.45
10.57%
-3.88
12.88%
-4.14
6.58%
-14.87
259.71%
-10.41
30.02%
-7.80
25.02%
-16.66
113.49%
-2.26
86.44%
2.80
223.77%
-3.58
227.95%
ev to operating cash flow
-8.70
-
-7.20
17.28%
-4.98
30.73%
-6.42
28.73%
-24.67
284.44%
-9.03
63.41%
-10.54
16.81%
-10.43
1.05%
-2.70
74.17%
1.01
137.54%
-5.00
594.02%
ev to sales
1.21K
-
575.99
52.47%
59.32
-
17.84
69.93%
2.40
86.55%
-0.50
120.64%
2.95
695.17%
free cash flow per share
-1.27
-
-1.56
22.83%
-1.71
9.41%
-1.12
34.51%
-1.19
6.68%
-5.94
398.17%
-3.88
34.64%
-4.09
5.40%
-3.11
24.00%
-1.96
37.11%
-1.66
15.04%
free cash flow yield
-0.08
-
-0.12
54.23%
-0.18
51.58%
-0.10
45.33%
-0.04
62.25%
-0.15
302.75%
-0.13
14.97%
-0.14
10.40%
-0.39
180.25%
-1.09
181.06%
-0.23
78.76%
graham net net
5.58
-
-0.37
106.55%
-2.09
472.53%
3.61
272.65%
6.00
66.34%
9.58
59.53%
5.06
47.20%
4.20
16.97%
1.95
53.56%
2.55
30.90%
-0.36
114.05%
graham number
16.81
-
5.52
67.18%
9.68
75.50%
11.90
22.90%
15.71
32.01%
30.69
95.36%
30.28
1.33%
30.67
1.29%
19.69
35.81%
14.57
26.01%
9.06
37.82%
income quality
0.57
-
0.15
73.29%
0.77
401.74%
0.64
16.72%
0.59
6.70%
1.04
75.04%
0.51
50.76%
0.54
6.33%
0.75
37.45%
0.52
30.05%
0.74
41.50%
intangibles to total assets
0
-
0
0
0
0
0.17
Infinity%
0.16
0.61%
0.10
37.18%
0.09
14.68%
0.01
87.48%
0.02
121.19%
interest coverage
-3.46K
-
933.13
126.95%
86.74
90.70%
278.65
221.24%
-717.90
357.64%
-3.23K
349.80%
37.66
101.17%
-0.91
-
interest debt per share
-0.00
-
0.50
78,243.01%
0.48
3.83%
0.27
42.76%
0.25
9.85%
0.18
27.71%
0.12
33.27%
0.12
1.46%
0.16
36.05%
2.22
1,296.16%
1.47
33.90%
inventory turnover
0.87
-
7.01
709.34%
6.58
6.09%
2.58
60.84%
0.94
63.62%
invested capital
-3.29
-
-0.24
92.69%
0.07
129.82%
0.04
45.80%
0.01
64.77%
0.03
120.12%
0.02
47.45%
0.03
61.77%
0.03
17.63%
0.81
2,593.15%
market cap
43.63M
-
38.03M
12.83%
31.15M
18.10%
64.25M
106.27%
199.92M
211.16%
340.70M
70.42%
296.48M
12.98%
325.83M
9.90%
108.88M
66.58%
24.43M
77.56%
95.66M
291.58%
net current asset value
14.85M
-
-710.00K
104.78%
-6.34M
793.58%
20.52M
423.43%
37.25M
81.54%
88.62M
137.89%
52.53M
40.72%
49.86M
5.08%
31.63M
36.57%
44.12M
39.49%
8.24M
81.32%
net debt to ebitda
2.64
-
1.44
45.64%
0.52
63.99%
2.74
429.22%
3.95
44.38%
3.34
15.63%
1.64
50.92%
3.44
110.13%
1.14
66.85%
6.00
425.60%
-0.15
102.48%
net income per share
-2.20
-
-9.16
317.18%
-2.22
75.76%
-1.69
23.82%
-1.75
3.47%
-3.24
85.13%
-5.36
65.30%
-5.66
5.73%
-2.78
51.01%
-2.89
4.06%
-2.02
30.18%
operating cash flow per share
-1.25
-
-1.40
11.44%
-1.70
21.62%
-1.08
36.56%
-1.04
3.46%
-3.37
224.05%
-2.42
28.17%
-2.34
3.25%
-1.97
15.85%
-1.55
21.65%
-1.49
3.28%
payables turnover
0.01
-
0.01
28.28%
0.77
-
2.59
236.72%
2.62
1.18%
4.81
83.52%
3.36
30.25%
receivables turnover
1
-
3.19
-
3.26
2.03%
3.08
5.59%
3.32
7.97%
3.34
0.57%
research and ddevelopement to revenue
116.55
-
85.42
26.71%
2.36
-
0.76
67.90%
0.48
36.89%
0.37
22.38%
0.26
30.06%
return on tangible assets
-0.37
-
-2.32
526.11%
-1.24
46.61%
-0.34
72.42%
-0.24
30.00%
-0.29
21.57%
-0.60
106.53%
-0.55
8.89%
-0.30
45.17%
-0.41
38.24%
-0.37
11.41%
revenue per share
0.01
-
0.01
77.22%
0.43
-
1.37
218.39%
2.22
61.69%
3.16
42.50%
2.54
19.72%
roe
-0.38
-
62.06
16,260.06%
1.18
98.09%
-0.45
138.42%
-0.28
38.56%
-0.25
10.19%
-0.70
180.62%
-0.77
8.95%
-0.45
41.75%
-0.88
97.80%
-1.11
26.08%
roic
-0.38
-
27.09
7,147.36%
-1.57
105.78%
0.42
127.12%
-0.27
163.35%
-0.23
14.27%
-0.59
154.02%
-0.53
9.55%
-0.42
20.97%
-0.59
41.00%
-0.69
17.74%
sales general and administrative to revenue
158.32
-
65.36
58.72%
6.62
-
1.30
80.38%
0.79
39.33%
0.54
30.95%
0.75
37.75%
shareholders equity per share
5.72
-
-0.15
102.58%
-1.88
1,170.70%
3.72
298.28%
6.27
68.42%
12.92
106.15%
7.61
41.10%
7.38
2.96%
6.21
15.90%
3.27
47.39%
1.81
44.62%
stock based compensation to revenue
92.26
-
32.30
64.99%
1.77
-
0.52
70.81%
0.26
50.14%
0.16
36.86%
0.21
31.00%
tangible asset value
14.94M
-
-422.21K
102.83%
-6.09M
1,341.80%
20.78M
441.42%
38.54M
85.43%
90.68M
135.28%
76.77M
15.34%
90.36M
17.71%
95.76M
5.97%
65.87M
31.21%
22.33M
66.11%
tangible book value per share
5.72
-
-0.15
102.58%
-1.88
1,170.70%
3.72
298.28%
6.27
68.42%
10.70
70.77%
8.00
25.22%
8.18
2.25%
7.04
14.00%
4.83
31.40%
1.67
65.38%
working capital
14.85M
-
10.10M
31.95%
4.52M
55.30%
26.13M
478.71%
38.75M
48.28%
88.69M
128.88%
53.55M
39.62%
66.05M
23.33%
48.78M
26.14%
56.42M
15.65%
42.62M
24.46%

All numbers in USD (except ratios and percentages)